Loading company…
Silexon develops pharmaceuticals using AI and big data through its AI4D and AI4Pat platforms.
Established in 2018 and based in Nanjing, China, Silexon is a pharmaceutical service provider that develops drugs using artificial intelligence and big data technology. Its main products are the AI4D platform, which provides drug discovery, design and development services, and the AI4Pat platform. Stage listed as Series A.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in